1-3 of 3
Sumiyuki Nishida
Close
Sort by
Journal Articles

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

Haruo Sugiyama, MD, PhD, Akihiro Tsuboi, Yoshihiro Oka, MD, PhD, Taiichi Kyo, Yuuta Katayama, Elisseeva Olga, Manabu Kawakami, Naoki Hosen, Sumiyuki Nishida, Soyoko Morimoto, Ayako Murao, Hiroko Nakajima, Ichiro Kawase, Yusuke Oji, MD, PhD, Hiroo Dohy
Journal: Blood
Blood (2010) 116 (21): 3295.
https://doi.org/10.1182/blood.V116.21.3295.3295
Published: 2010
Journal Articles

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1

Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Keisuke Kanato, Masashi Yanagihara, Shin-ichi Nakatsuka, Yoshihiko Hoshida, Tsutomu Nakazawa, Yukie Harada, Naoya Tatsumi, Akihiro Tsuboi, Manabu Kawakami, Yoshihiro Oka, Yusuke Oji, Katsuyuki Aozasa, Ichiro Kawase, Haruo Sugiyama
Journal: Blood
Blood (2006) 107 (8): 3303–3312.
https://doi.org/10.1182/blood-2005-04-1656
Published: 2006
Journal Articles

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Clinical Trials & Observations
Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame, Toshihiro Soma, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Journal: Blood
Blood (2003) 101 (5): 1698–1704.
https://doi.org/10.1182/blood-2002-06-1831
Published: 2003